[
    [
        {
            "time": "2021-04-30",
            "original_text": "复星医药：目前子公司mRNA新冠疫苗于中国境内尚处于II期临床试验阶段",
            "features": {
                "keywords": [
                    "复星医药",
                    "mRNA",
                    "新冠疫苗",
                    "II期临床试验"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药：目前子公司mRNA新冠疫苗于中国境内尚处于II期临床试验阶段",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-30",
            "original_text": "主力动向｜54股主力买入超亿元！复星医药、华东医药、隆基股份、东方财富、赣锋锂业位居前五！",
            "features": {
                "keywords": [
                    "主力资金",
                    "复星医药",
                    "买入",
                    "超亿元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "主力动向｜54股主力买入超亿元！复星医药、华东医药、隆基股份、东方财富、赣锋锂业位居前五！",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-30",
            "original_text": "港股收盘(4.30)|恒指收跌1.97%，复必泰疫苗接近获批，复星医药(02196)逆势涨逾7%",
            "features": {
                "keywords": [
                    "港股",
                    "恒指",
                    "复必泰疫苗",
                    "复星医药",
                    "逆势上涨"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股收盘(4.30)|恒指收跌1.97%，复必泰疫苗接近获批，复星医药(02196)逆势涨逾7%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-30",
            "original_text": "北上资金加仓多只绩优疫苗股，9股增持超亿",
            "features": {
                "keywords": [
                    "北上资金",
                    "加仓",
                    "疫苗股",
                    "复星医药"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北上资金加仓多只绩优疫苗股，9股增持超亿",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-04-30",
            "original_text": "海外疫情持续！Q1业绩向好资金加仓疫苗及新冠检测等股大涨",
            "features": {
                "keywords": [
                    "海外疫情",
                    "Q1业绩",
                    "疫苗",
                    "新冠检测",
                    "复星医药"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "海外疫情持续！Q1业绩向好资金加仓疫苗及新冠检测等股大涨",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]